This Article  • Full text  • PDF  • VIDEO SUPPLEMENT  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (618)  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Topic Collections  • Randomized Controlled Trial  • Lipids and Lipid Disorders  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic

A Randomized Controlled Trial

Steven E. Nissen, MD; E. Murat Tuzcu, MD; Paul Schoenhagen, MD; B. Greg Brown, MD; Peter Ganz, MD; Robert A. Vogel, MD; Tim Crowe, BS; Gail Howard, MS; Christopher J. Cooper, MD; Bruce Brodie, MD; Cindy L. Grines, MD; Anthony N. DeMaria, MD; for the REVERSAL Investigators

JAMA. 2004;291:1071-1080.

Context  Statin drugs reduce both atherogenic lipoproteins and cardiovascular morbidity and mortality. However, the optimal strategy and target level for lipid reduction remain uncertain.

Objective  To compare the effect of regimens designed to produce intensive lipid lowering or moderate lipid lowering on coronary artery atheroma burden and progression.

Design, Setting, and Patients  Double-blind, randomized active control multicenter trial (Reversal of Atherosclerosis with Aggressive Lipid Lowering [REVERSAL]) performed at 34 community and tertiary care centers in the United States comparing the effects of 2 different statins administered for 18 months. Intravascular ultrasound was used to measure progression of atherosclerosis. Between June 1999 and September 2001, 654 patients were randomized and received study drug; 502 had evaluable intravascular ultrasound examinations at baseline and after 18 months of treatment.

Interventions  Patients were randomly assigned to receive a moderate lipid-lowering regimen consisting of 40 mg of pravastatin or an intensive lipid-lowering regimen consisting of 80 mg of atorvastatin.

Main Outcome Measures  The primary efficacy parameter was the percentage change in atheroma volume (follow-up minus baseline).

Results  Baseline low-density lipoprotein cholesterol level (mean, 150.2 mg/dL [3.89 mmol/L] in both treatment groups) was reduced to 110 mg/dL (2.85 mmol/L) in the pravastatin group and to 79 mg/dL (2.05 mmol/L) in the atorvastatin group (P<.001). C-reactive protein decreased 5.2% with pravastatin and 36.4% with atorvastatin (P<.001). The primary end point (percentage change in atheroma volume) showed a significantly lower progression rate in the atorvastatin (intensive) group (P = .02). Similar differences between groups were observed for secondary efficacy parameters, including change in total atheroma volume (P = .02), change in percentage atheroma volume (P<.001), and change in atheroma volume in the most severely diseased 10-mm vessel subsegment (P<.01). For the primary end point, progression of coronary atherosclerosis occurred in the pravastatin group (2.7%; 95% confidence interval [CI], 0.2% to 4.7%; P = .001) compared with baseline. Progression did not occur in the atorvastatin group (–0.4%; CI –2.4% to 1.5%; P = .98) compared with baseline.

Conclusions  For patients with coronary heart disease, intensive lipid-lowering treatment with atorvastatin reduced progression of coronary atherosclerosis compared with pravastatin. Compared with baseline values, patients treated with atorvastatin had no change in atheroma burden, whereas patients treated with pravastatin showed progression of coronary atherosclerosis. These differences may be related to the greater reduction in atherogenic lipoproteins and C- reactive protein in patients treated with atorvastatin.

Author Affiliations: Departments of Cardiovascular Medicine (Drs Nissen, Tuzcu, Schoenhagen, and Mr Crowe) and Diagnostic Radiology (Dr Schoenhagen), Cleveland Clinic Lerner School of Medicine, Cleveland, Ohio; Department of Medicine, University of Washington, Seattle (Dr Brown); Department of Medicine, Brigham and Women's Hospital, Boston, Mass (Dr Ganz); Department of Medicine, University of Maryland, Baltimore (Dr Vogel); Pfizer Inc, New York, NY (Ms Howard); Department of Medicine, Medical College of Ohio, Toledo (Dr Cooper); LeBauer Cardiovascular Research Foundation, Greensboro, NC (Dr Brodie); Cardiac Catheterization Laboratory, Division of Cardiac Diseases, William Beaumont Hospital, Royal Oak, Mich (Dr Grines); and Department of Medicine, University of California, San Diego (Dr DeMaria).

RELATED LETTERS

Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma
Uffe Ravnskov and Morley C. Sutter
JAMA. 2004;292(1):38.
EXTRACT | FULL TEXT  

Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma
Paul J. Rosch
JAMA. 2004;292(1):38-39.
EXTRACT | FULL TEXT  

Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma
Kavitha Rajaram
JAMA. 2004;292(1):39.
EXTRACT | FULL TEXT  

Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma
Pim van der Harst, Wiek H. van Gilst, and Felix Zijlstra
JAMA. 2004;292(1):39.
EXTRACT | FULL TEXT  

Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma—Reply
Steven Nissen and For the REVERSAL Investigators
JAMA. 2004;292(1):39-40.
EXTRACT | FULL TEXT  

RELATED ARTICLE

High-Intensity Statin Treatment for Coronary Heart Disease
Frank M. Sacks
JAMA. 2004;291(9):1132-1134.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Relationship Between Biomarkers of Oxidized Low-Density Lipoprotein, Statin Therapy, Quantitative Coronary Angiography, and Atheroma Volume Observations From the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) Study.
Choi et al.
J Am Coll Cardiol 2008;52:24-32.
ABSTRACT | FULL TEXT  

Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy
Bhavnani et al.
Europace 2008;10:854-859.
ABSTRACT | FULL TEXT  

Overview of clinical trials on calcific aortic stenosis
Pedersen
Eur Heart J Suppl 2008;10:E31-E40.
ABSTRACT | FULL TEXT  

Impact of Plasma Oxidized Low-Density Lipoprotein Removal on Atherosclerosis
Ishigaki et al.
Circulation 2008;118:75-83.
ABSTRACT | FULL TEXT  

Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis
Han et al.
Eur Heart J 2008;29:1359-1369.
ABSTRACT | FULL TEXT  

Effect of Rosuvastatin Therapy on Coronary Artery Stenoses Assessed by Quantitative Coronary Angiography: A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden
Ballantyne et al.
Circulation 2008;117:2458-2466.
ABSTRACT | FULL TEXT  

Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study
Sipahi et al.
Heart 2008;94:623-627.
ABSTRACT | FULL TEXT  

The Influence of Pravastatin and Atorvastatin on Markers of Oxidative Stress in Hypercholesterolemic Humans
Ky et al.
J Am Coll Cardiol 2008;51:1653-1662.
ABSTRACT | FULL TEXT  

Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes: The PERISCOPE Randomized Controlled Trial
Nissen et al.
JAMA 2008;299:1561-1573.
ABSTRACT | FULL TEXT  

Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease: The STRADIVARIUS Randomized Controlled Trial
Nissen et al.
JAMA 2008;299:1547-1560.
ABSTRACT | FULL TEXT  

Ultrasound imaging techniques for the evaluation of cardiovascular therapies
Kastelein and de Groot
Eur Heart J 2008;29:849-858.
ABSTRACT | FULL TEXT  

Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis.
Ibanez et al.
J Am Coll Cardiol 2008;51:1104-1109.
ABSTRACT | FULL TEXT  

Association Between ADAMTS1 Matrix Metalloproteinase Gene Variation, Coronary Heart Disease, and Benefit of Statin Therapy
Sabatine et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:562-567.
ABSTRACT | FULL TEXT  

The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials
Josan et al.
CMAJ 2008;178:576-584.
ABSTRACT | FULL TEXT  

Lower extremity vein graft failure: a translational approach
Owens et al.
Vasc Med 2008;13:63-74.
ABSTRACT  

Lipid Management to Reduce Cardiovascular Risk: A New Strategy Is Required
Superko and King
Circulation 2008;117:560-568.
FULL TEXT  

Standards of Medical Care in Diabetes--2008
American Diabetes Association
Diabetes Care 2008;31:S12-S54.
FULL TEXT  

Risk factor status and vascular events in patients with symptomatic intracranial stenosis
Chaturvedi et al.
Neurology 2007;69:2063-2068.
ABSTRACT | FULL TEXT  

Role of Inflammation in Initiation and Perpetuation of Atrial Fibrillation: A Systematic Review of the Published Data
Issac et al.
J Am Coll Cardiol 2007;50:2021-2028.
ABSTRACT | FULL TEXT  

Beyond Low-Density Lipoprotein Cholesterol: Defining the Role of Low-Density Lipoprotein Heterogeneity in Coronary Artery Disease
Mudd et al.
J Am Coll Cardiol 2007;50:1735-1741.
ABSTRACT | FULL TEXT  

Impact of C-reactive protein on treatment of patients with cardiovascular disease
Gortney and Sanders
Am J Health Syst Pharm 2007;64:2009-2016.
ABSTRACT | FULL TEXT  

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
Authors/Task Force Members et al.
Eur Heart J 2007;28:2375-2414.
FULL TEXT  

Assessment of Culprit Lesion Morphology in Acute Myocardial Infarction: Ability of Optical Coherence Tomography Compared With Intravascular Ultrasound and Coronary Angioscopy
Kubo et al.
J Am Coll Cardiol 2007;50:933-939.
ABSTRACT | FULL TEXT  

Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin
Laudi et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 2007;293:L630-L638.
ABSTRACT | FULL TEXT  

Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials
Afilalo et al.
Heart 2007;93:914-921.
ABSTRACT | FULL TEXT  

Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal-medial thickness in patients with coronary heart disease
Yu et al.
Heart 2007;93:933-939.
ABSTRACT | FULL TEXT  

How can adherence to lipid-lowering medication be improved? A systematic review of randomized controlled trials
Schedlbauer et al.
Fam Pract 2007;24:380-387.
ABSTRACT | FULL TEXT  

{beta}-Blockers and Progression of Coronary Atherosclerosis: Pooled Analysis of 4 Intravascular Ultrasonography Trials
Sipahi et al.
ANN INTERN MED 2007;147:10-18.
ABSTRACT | FULL TEXT  

Plaque Temperature, Arterial Remodeling, and Inflammation: Understanding "Hot-Spots" in the Coronary Arteries
Schoenhagen
J Am Coll Cardiol 2007;49:2272-2273.
FULL TEXT  

Intravascular ultrasound radiofrequency analysis of coronary atherosclerosis: an emerging technology for the assessment of vulnerable plaque
Mehta et al.
Eur Heart J 2007;28:1283-1288.
ABSTRACT | FULL TEXT  

Low-Density Lipoprotein-Dependent and -Independent Effects of Cholesterol-Lowering Therapies on C-Reactive Protein: A Meta-Analysis
Kinlay
J Am Coll Cardiol 2007;49:2003-2009.
ABSTRACT | FULL TEXT  

Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targets
Lee and Choudhury
Heart 2007;93:559-564.
ABSTRACT | FULL TEXT  

Endothelial Mitochondria: Contributing to Vascular Function and Disease
Davidson and Duchen
Circ. Res. 2007;100:1128-1141.
ABSTRACT | FULL TEXT  

Rate of Progression of Coronary Atherosclerotic Plaque in Women
Nicholls et al.
J Am Coll Cardiol 2007;49:1546-1551.
ABSTRACT | FULL TEXT  

A Direct Comparison of Intravascular Ultrasound and Quantitative Coronary Arteriography: Implications for Measures of Atherosclerosis as Clinical Surrogates
Brown
Circulation 2007;115:1824-1826.
FULL TEXT  

Use of maximum-dose simvastatin or atorvastatin in an ethnically diverse population
Song et al.
Am J Health Syst Pharm 2007;64:767-772.
ABSTRACT | FULL TEXT  

Post-Cardiothoracic Surgery Atrial Fibrillation: A Review of Preventive Strategies
Baker and White
The Annals of Pharmacotherapy 2007;41:587-598.
ABSTRACT | FULL TEXT  

Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
Nissen et al.
NEJM 2007;356:1304-1316.
ABSTRACT | FULL TEXT  

Impact of Metabolic Syndrome on Tissue Characteristics of Angiographically Mild to Moderate Coronary Lesions: Integrated Backscatter Intravascular Ultrasound Study
Amano et al.
J Am Coll Cardiol 2007;49:1149-1156.
ABSTRACT | FULL TEXT  

Is Intravascular Ultrasound the Gold Standard Surrogate for Clinically Relevant Atherosclerosis Progression?
Brown and Zhao
J Am Coll Cardiol 2007;49:933-938.
ABSTRACT | FULL TEXT  

Intravascular Ultrasound for the Evaluation of Therapies Targeting Coronary Atherosclerosis
Bose et al.
J Am Coll Cardiol 2007;49:925-932.
ABSTRACT | FULL TEXT  

Functional Analysis of the Hepatic HMG-CoA Reductase Promoter by In Vivo Electroporation
Lagor et al.
Exp. Biol. Med. 2007;232:353-361.
ABSTRACT | FULL TEXT  

Biomarkers in the Prevention and Treatment of Atherosclerosis: Need, Validation, and Future
Revkin et al.
Pharmacol. Rev. 2007;59:40-53.
ABSTRACT | FULL TEXT  

Enhanced Expression of the Homeostatic Chemokines CCL19 and CCL21 in Clinical and Experimental Atherosclerosis: Possible Pathogenic Role in Plaque Destabilization
Damas et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:614-620.
ABSTRACT | FULL TEXT  

Statin Therapy and the Elderly: SAGE Advice?
Gotto
Circulation 2007;115:681-683.
FULL TEXT  

Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart Disease: Results of the Study Assessing Goals in the Elderly (SAGE)
Deedwania et al.
Circulation 2007;115:700-707.
ABSTRACT | FULL TEXT  

Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis
Nicholls et al.
JAMA 2007;297:499-508.
ABSTRACT | FULL TEXT  

The effect of intensive lipid lowering on coronary atheroma and clinical outcome
Houslay et al.
Heart 2007;93:149-151.
ABSTRACT | FULL TEXT  

Is it Time for a Cardiovascular Primary Prevention Trial in the Elderly?
Robinson et al.
Stroke 2007;38:441-450.
ABSTRACT | FULL TEXT  

Redefining Risk in Acute Coronary Syndromes Using Molecular Medicine
Anwaruddin et al.
J Am Coll Cardiol 2007;49:279-289.
ABSTRACT | FULL TEXT  

Coronary Artery Calcification and Changes in Atheroma Burden in Response to Established Medical Therapies
Nicholls et al.
J Am Coll Cardiol 2007;49:263-270.
ABSTRACT | FULL TEXT  

Atherosclerosis Regression, Vascular Remodeling, and Plaque Stabilization
Klein
J Am Coll Cardiol 2007;49:271-273.
FULL TEXT  

Standards of Medical Care in Diabetes--2007
American Diabetes Association
Diabetes Care 2007;30:S4-S41.
FULL TEXT  

An Initial Strategy of Intensive Medical Therapy Is Comparable to That of Coronary Revascularization for Suppression of Scintigraphic Ischemia in High-Risk But Stable Survivors of Acute Myocardial Infarction
Mahmarian et al.
J Am Coll Cardiol 2006;48:2458-2467.
ABSTRACT | FULL TEXT  

Rethinking Primary Prevention of Atherosclerosis-Related Diseases
Napoli et al.
Circulation 2006;114:2517-2527.
FULL TEXT  

Suppression of Rage as a Basis of Simvastatin-Dependent Plaque Stabilization in Type 2 Diabetes
Cuccurullo et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:2716-2723.
ABSTRACT | FULL TEXT  

Vascular Protection of Dual Therapy (Atorvastatin-Amlodipine) in Hypertensive Patients
Martin-Ventura et al.
J. Am. Soc. Nephrol. 2006;17:S189-S193.
ABSTRACT | FULL TEXT  

Efficacy and Safety of Torcetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor, in Individuals With Below-Average High-Density Lipoprotein Cholesterol Levels on a Background of Atorvastatin
McKenney et al.
J Am Coll Cardiol 2006;48:1782-1790.
ABSTRACT | FULL TEXT  

Reply
Nicholls et al.
J Am Coll Cardiol 2006;48:1915-1916.
FULL TEXT  

Comparative effects of pitavastatin and probucol on oxidative stress, Cu/Zn superoxide dismutase, PPAR-{gamma}, and aortic stiffness in hypercholesterolemia
Umeji et al.
Am. J. Physiol. Heart Circ. Physiol. 2006;291:H2522-H2532.
ABSTRACT | FULL TEXT  

High-Dose Statins and Atherosclerosis Regression--Reply
Nissen
JAMA 2006;296:1837-1837.
FULL TEXT  

Potent Reduction of Apolipoprotein B and Low-Density Lipoprotein Cholesterol by Short-Term Administration of an Antisense Inhibitor of Apolipoprotein B
Kastelein et al.
Circulation 2006;114:1729-1735.
ABSTRACT | FULL TEXT  

The Effect of Early, Intensive Statin Therapy on Acute Coronary Syndrome: A Meta-analysis of Randomized Controlled Trials.
Hulten et al.
Arch Intern Med 2006;166:1814-1821.
ABSTRACT | FULL TEXT  

Cardiac multidetector computed tomography (MDCT): method, indications and applications
leonard et al.
Imaging 2006;18:151-159.
ABSTRACT | FULL TEXT  

Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
Kontush and Chapman
Pharmacol. Rev. 2006;58:342-374.
ABSTRACT | FULL TEXT  

Bioavailability of amlodipine besylate/atorvastatin calcium combination tablet.
Chung et al.
J Clin Pharmacol 2006;46:1030-1037.
ABSTRACT | FULL TEXT  

Angiogenesis in Atherogenesis
Herrmann et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:1948-1957.
ABSTRACT | FULL TEXT  

Recent Advances of Intervention to Inhibit Progression of Carotid Intima-Media Thickness in Patients With Type 2 Diabetes Mellitus
Yokoyama et al.
Stroke 2006;37:2420-2427.
ABSTRACT | FULL TEXT  

Optimal Blood Pressure Levels in Patients With Coronary Artery Disease
Tobis and Fonarow
J Am Coll Cardiol 2006;48:839-840.
FULL TEXT  

Effects of Normal, Pre-Hypertensive, and Hypertensive Blood Pressure Levels on Progression of Coronary Atherosclerosis
Sipahi et al.
J Am Coll Cardiol 2006;48:833-838.
ABSTRACT | FULL TEXT  

Measuring Effects of Antiatherosclerotic Therapies
Spence
J Am Coll Cardiol 2006;48:845-846.
FULL TEXT  

Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art
Crouse
J. Lipid Res. 2006;47:1677-1699.
ABSTRACT | FULL TEXT